InternationalUSRemember you can easily switch between MIP US and MIP International at any time

European Commission claims pharma competition success

Legal Media Group


The proportion of problematic patent settlements in the pharmaceutical industry has fallen, even though the number of settlements has grown, according to the European Commission

In a statement published on January 31, the Commission said that its third annual survey had found that 11% of antitrust settlements were potentially problematic from an antitrust point of view, compared to 21% when the pharmaceutical sector enquiry was...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

The Autolex Automotive Legal Forum, Detroit – open for registrations, with @ManagingIP. Click… https://t.co/DAxSRRJ0Y4

Oct 23 2017 03:23 ·  reply ·  retweet ·  favourite
ManagingIP profile

Congratulations Grant! https://t.co/6Apm3xHAR5

Oct 23 2017 03:13 ·  reply ·  retweet ·  favourite
ManagingIP profile

RT @FordhamIP: Posner On Copyright: 10 Cases To Remember by @dkluft https://t.co/2WDXWFr5Rm

Oct 23 2017 02:44 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


null null null

null null null

October 2017

Courts grapple with scope of patent protection

The Supreme Court’s decision in Actavis v Eli Lilly introduced a doctrine of equivalents and arguably also established a doctrine of prosecution history estoppel in the UK. We look at the law across Europe, and the impact the decision might have. Kingsley Egbuonu, Michael Loney and James Nurton set the scene



Most read articles

Supplements